Navigation Links
Stopping Statins After Stroke Doubles Death Risk
Date:8/30/2007

Almost 40% of patients stopped taking drugs in Italian study

THURSDAY, Aug. 30 (HealthDay News) -- Stroke survivors who stopped taking cholesterol-lowering statins doubled their risk of dying in the next year compared to those who stayed on the medications, an Italian study finds.

A number of other studies have shown the benefits of using statins after a stroke, the study authors noted.

For instance, the Italian study comes on the heels of a Spanish study that found discontinuation of statin therapy by stroke patients is associated with an increased risk of death or dependency after 90 days.

The Spanish study of 89 people who had been taking statins before suffering a stroke found that 27 of the 46 patients who had an interruption of statin therapy were dead or dependent after three months, compared to only 16 of 43 who did not stop taking statins.

The American Heart Association currently recommends statin therapy after a stroke, said Dr. Larry Goldstein, director of the stroke center at Duke University. That recommendation was made before completion of a U.S. study "that showed for the first time that starting patients with no known cardiac disease after a stroke produced a significant reduction in the rate of recurrent stroke and in fatal stroke," Goldstein said.

The Italian study, by physicians at the San Filippo Neri Hospital in Rome and published in the Aug. 31 issue of Stroke, was "very well done," Goldstein said. It followed 631 stroke survivors whose average age was 70 and who had no other major illness, including heart disease. All were discharged from the hospital with orders to take a drug regimen that included statins.

But by the end of the four-and-a-half-year study, 38.9 percent of the patients had stopped taking statins, most of them quickly. The average time to discontinuation was 48.6 days.

A statistical analysis showed that discontinuing statin therapy was an independent risk factor for death from all causes. Eighty percent of the deaths recorded in the study were from cardiovascular disease.

About a quarter of the patients who stopped taking statins cited mild side effects, the most common of which was indigestion. No specific reason for discontinuing the drug therapy was given by the other patients or their doctors.

Current practice at Duke is to prescribe statins in many cases after a stroke, Goldstein said. "A patient who has coronary heart disease or diabetes should be on a statin," he said. "If there is no known coronary heart disease, we prescribe a statin for someone whose LDL cholesterol is between 100 and 190."

The Italian study also showed an increased risk of death in stroke survivors who stopped taking an anti-clotting drug such as Plavix, Goldstein noted. Their risk of death was 80 percent higher than in patients who took the drug as prescribed.

"Discontinuing either statins or antiplatelet drugs was associated with an increase in all-cause mortality," Goldstein said.

"Effective clinical strategies are needed to bring out a significant increase in patients who maintain their drug therapies," study author Dr. Furio Colivicchi said in a statement.

Many stroke survivors are eager to stop taking the medications, said Dr. Matthew Fink, chief of the division of stroke and critical care neurology at Weill Cornell Medical College in New York City. They generally are older people who are vulnerable to arthritis, he said.

"They have a tendency to have aches and pains, and they blame them on the statin," he said. "It's not due to the drug, but it's hard to convince them."

The two new reports both show that "most people who have had ischemic strokes should be treated with statins as part of their overall treatment," Fink said. Most strokes are ischemic, caused by blockage of a brain artery by a clot.

"The Spanish study looked at the acute effects in the hospital," Fink said. "The Italian study looked at the effect on outpatients. Both studies show the importance of continuing on these medications. When you start them, stay on them," he said.

More information

Complete information on stroke treatment and recovery is provided by the National Library of Medicine.



SOURCES: Larry Goldstein, M.D., director, stroke center, Duke University, Durham, N.C.; Matthew Fink, M.D., chief of the division of stroke and critical care neurology, Weill Cornell Medical College, New York City; Aug. 31, 2007, Stroke


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Therapy for stopping the spread of cancer cells
2. Stopping Prostate Cancer from Spreading
3. Stopping The Progression Of Parkinsons Disease
4. Stopping The Growth Of Viruses
5. Stopping The Growth Of Viruses
6. The Consequences Of Stopping Physical Activity
7. Study Finds Parkinson’s Cell Death Blocked by Stopping Inflammatory Facto
8. The Odds Of Stopping Smoking
9. Statins reduce heart attacks
10. The Effects of Statins Questioned
11. Statins reduce risks for angioplasty patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... Atlanta, GA (PRWEB) , ... March 23, 2017 ... ... announced the release of SmartBen NOW, an innovative mobile app and centralized benefits ... gather and present critical information securely from multiple locations. For the first time, ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the greater Fort Collins area, has unveiled a collaboration with nonprofit ... involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, ... announced rapid completion of the strategic executive team expansion needed to further optimize ... the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, ... build on a solid foundation. As experts in dangerous situations the Inflow IQ ... coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017 Research and Markets has announced the ... to their offering. ... The global capillary electrophoresis market to grow at a CAGR ... Global Capillary Electrophoresis Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:3/23/2017)... 2017 Newborns are highly vulnerable to ... because their young immune systems typically mount weak ... report achieving strong vaccine responses in newborn animals, ... human trials — by adding compounds known as ... simultaneous papers, they also describe improved adjuvant formulations ...
(Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
Breaking Medicine Technology: